Evidence map›Paper›PMID 31289621›Full record

ArticleOncotarget2019

Erratum: CRIPTO overexpression promotes mesenchymal differentiation in prostate carcinoma cells through parallel regulation of AKT and FGFR activities.

Stéphane Terry, Ihsan Y El-Sayed, Damien Destouches, Pascale Maillé, Nathalie Nicolaiew, Guillaume Ploussard, Fannie Semprez, Cynthia Pimpie, Himisha Beltran, Arturo Londono-Vallejo and 4 more

Abstract readPublished Erratum
PubMed Full text at PMC Publisher
In one paragraph

Article in Oncotarget, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

14 authors.

Stéphane TerryInserm, U955, Equipe 7, Créteil, France.
Ihsan Y El-SayedInserm, U955, Equipe 7, Créteil, France.
Damien DestouchesInserm, U955, Equipe 7, Créteil, France.
Pascale MailléAP-HP, Hôpital H. Mondor, Département de pathologie, F-94000, Créteil, France.
Nathalie NicolaiewInserm, U955, Equipe 7, Créteil, France.
Guillaume PloussardInserm, U955, Equipe 7, Créteil, France.
Fannie SemprezInserm, U955, Equipe 7, Créteil, France.
Cynthia PimpieInserm, U955, Equipe 7, Créteil, France.
Himisha BeltranDepartment of Medicine, Weill Cornell Medical College, New York, NY, 10065, USA.
Arturo Londono-VallejoInstitut Curie, Centre de Recherche, CNRS UMR 3244, Paris, F-75248, France.
Yves AlloryInserm, U955, Equipe 7, Créteil, France.
Alexandre de la Taille *Inserm, U955, Equipe 7, Créteil, France.
David S Salomon *Mouse Cancer Genetics Program, Center for Cancer Research, Frederick National Laboratory for Cancer Research, Frederick, MD, 21702, USA.
Francis Vacherot *Inserm, U955, Equipe 7, Créteil, France.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

[This corrects the article DOI: 10.18632/oncotarget.2740.].

Identifiers

PMID31289621
PMCPMC6609255

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.